17825800

Source:http://linkedlifedata.com/resource/pubmed/id/17825800

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0011570, umls-concept:C0034897, umls-concept:C0078569, umls-concept:C0205178, umls-concept:C0309872, umls-concept:C0332189, umls-concept:C0439234, umls-concept:C0585064, umls-concept:C1274040, umls-concept:C1708528, umls-concept:C2603343
pubmed:issue	12
pubmed:dateCreated	2007-12-6
pubmed:abstractText	We evaluated the comparative efficacy and safety of venlafaxine extended release (ER) and fluoxetine in the acute and continuation phases of treatment.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/K23 MH086690-03
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17825800
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0213264
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclohexanols, http://linkedlifedata.com/resource/pubmed/chemical/Fluoxetine, http://linkedlifedata.com/resource/pubmed/chemical/venlafaxine
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1873-2402
pubmed:author	pubmed-author:AhmedSaeeduddinS, pubmed-author:DunlopBoadie WBW, pubmed-author:DunnerDavid LDL, pubmed-author:FergusonJames MJM, pubmed-author:FriedmanEdward SES, pubmed-author:GelenbergAlan JAJ, pubmed-author:HirschfeldRobert MRM, pubmed-author:KellerMartin BMB, pubmed-author:KocsisJames HJH, pubmed-author:KornsteinSusan GSG, pubmed-author:NemeroffCharles BCB, pubmed-author:NinanPhilip TPT, pubmed-author:PedersenRonR, pubmed-author:RothschildAnthony JAJ, pubmed-author:SchatzbergAlan FAF, pubmed-author:SchmidtMichaelM, pubmed-author:SheltonRichard CRC, pubmed-author:ThaseMichael EME, pubmed-author:TrivediMadhukar HMH, pubmed-author:YanBingB, pubmed-author:ZajeckaJohn MJM
pubmed:issnType	Electronic
pubmed:day	15
pubmed:volume	62
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1371-9
pubmed:dateRevised	2011-2-10
pubmed:meshHeading	pubmed-meshheading:17825800-Adolescent, pubmed-meshheading:17825800-Adult, pubmed-meshheading:17825800-Analysis of Variance, pubmed-meshheading:17825800-Antidepressive Agents, Second-Generation, pubmed-meshheading:17825800-Cyclohexanols, pubmed-meshheading:17825800-Depression, pubmed-meshheading:17825800-Double-Blind Method, pubmed-meshheading:17825800-Drug Administration Schedule, pubmed-meshheading:17825800-Drug Evaluation, pubmed-meshheading:17825800-Female, pubmed-meshheading:17825800-Fluoxetine, pubmed-meshheading:17825800-Follow-Up Studies, pubmed-meshheading:17825800-Humans, pubmed-meshheading:17825800-Male, pubmed-meshheading:17825800-Middle Aged, pubmed-meshheading:17825800-Recurrence, pubmed-meshheading:17825800-Retrospective Studies, pubmed-meshheading:17825800-Severity of Illness Index, pubmed-meshheading:17825800-Treatment Outcome
pubmed:year	2007
pubmed:articleTitle	The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
pubmed:affiliation	Brown University, Providence, Rhode Island 02906, USA. martin_keller@brown.edu
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study